Safety and efficacy of axitinib in combination with pembrolizumab in patients with advanced renal cell cancer

Safety and efficacy of axitinib in combination with pembrolizumab in patients with advanced renal cell cancer

Cancer-News

2 years
189 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center discusses the efficacy of axitinib in combination with pembrolizumab in patients with advanced renal cell cancer.
Up Next Autoplay